BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 28546357)

  • 21. Microbiota and the liver.
    Shen TD; Pyrsopoulos N; Rustgi VK
    Liver Transpl; 2018 Apr; 24(4):539-550. PubMed ID: 29316191
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The gut microbiota, a new cardiovascular risk factor?].
    Chong-Nguyen C; Duboc H; Sokol H
    Presse Med; 2017; 46(7-8 Pt 1):708-713. PubMed ID: 28756077
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Depletion of the gut microbiota enhances the blood pressure-lowering effect of captopril: implication of the gut microbiota in resistant hypertension.
    Kyoung J; Yang T
    Hypertens Res; 2022 Sep; 45(9):1505-1510. PubMed ID: 35513487
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New drug targets for hypertension: A literature review.
    Gao Q; Xu L; Cai J
    Biochim Biophys Acta Mol Basis Dis; 2021 Mar; 1867(3):166037. PubMed ID: 33309796
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gut microbiota and chronic kidney disease: implications for novel mechanistic insights and therapeutic strategies.
    Pan W; Kang Y
    Int Urol Nephrol; 2018 Feb; 50(2):289-299. PubMed ID: 28849345
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Probiotics, prebiotics and colorectal cancer prevention.
    Ambalam P; Raman M; Purama RK; Doble M
    Best Pract Res Clin Gastroenterol; 2016 Feb; 30(1):119-31. PubMed ID: 27048903
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Microbiota-Gut-Brain Axis in Neuropsychiatric Disorders: Pathophysiological Mechanisms and Novel Treatments.
    Kim YK; Shin C
    Curr Neuropharmacol; 2018; 16(5):559-573. PubMed ID: 28925886
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modulation of gut microbiome in nonalcoholic fatty liver disease: pro-, pre-, syn-, and antibiotics.
    Cho MS; Kim SY; Suk KT; Kim BY
    J Microbiol; 2018 Dec; 56(12):855-867. PubMed ID: 30377993
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gut microbiota: novel therapeutic target for nonalcoholic fatty liver disease.
    Suk KT; Kim DJ
    Expert Rev Gastroenterol Hepatol; 2019 Mar; 13(3):193-204. PubMed ID: 30791767
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypertension-Linked Pathophysiological Alterations in the Gut.
    Santisteban MM; Qi Y; Zubcevic J; Kim S; Yang T; Shenoy V; Cole-Jeffrey CT; Lobaton GO; Stewart DC; Rubiano A; Simmons CS; Garcia-Pereira F; Johnson RD; Pepine CJ; Raizada MK
    Circ Res; 2017 Jan; 120(2):312-323. PubMed ID: 27799253
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mind-altering with the gut: Modulation of the gut-brain axis with probiotics.
    Kim N; Yun M; Oh YJ; Choi HJ
    J Microbiol; 2018 Mar; 56(3):172-182. PubMed ID: 29492874
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sexual Dimorphic Interplays Between Gut Microbiota and Antihypertensive Drugs.
    Bardhan P; Yang T
    Curr Hypertens Rep; 2023 Aug; 25(8):163-172. PubMed ID: 37199902
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Gut microbiota and efficacy of cancer therapies].
    Vétizou M; Daillère R; Zitvogel L
    Biol Aujourdhui; 2017; 211(1):51-67. PubMed ID: 28682227
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gut Microbial Changes, Interactions, and Their Implications on Human Lifecycle: An Ageing Perspective.
    Vemuri R; Gundamaraju R; Shastri MD; Shukla SD; Kalpurath K; Ball M; Tristram S; Shankar EM; Ahuja K; Eri R
    Biomed Res Int; 2018; 2018():4178607. PubMed ID: 29682542
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Potential role of the gut microbiota in synthetic torpor and therapeutic hypothermia.
    Sisa C; Turroni S; Amici R; Brigidi P; Candela M; Cerri M
    World J Gastroenterol; 2017 Jan; 23(3):406-413. PubMed ID: 28210076
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterisation and therapeutic manipulation of the gut microbiome in inflammatory bowel disease.
    Schulberg J; De Cruz P
    Intern Med J; 2016 Mar; 46(3):266-73. PubMed ID: 26968595
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Liver diseases: The pathogenetic role of the gut microbiome and the potential of treatment for its modulation].
    Aitbaev KA; Murkamilov IT; Fomin VV
    Ter Arkh; 2017; 89(8):120-128. PubMed ID: 28914862
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intestinal microbiota in liver disease.
    Haque TR; Barritt AS
    Best Pract Res Clin Gastroenterol; 2016 Feb; 30(1):133-42. PubMed ID: 27048904
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Brain-Gut-Microbiota Axis and Mental Health.
    Dinan TG; Cryan JF
    Psychosom Med; 2017 Oct; 79(8):920-926. PubMed ID: 28806201
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Probiotics and microbiota composition.
    Sanders ME
    BMC Med; 2016 Jun; 14(1):82. PubMed ID: 27250499
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.